News
-
-
-
-
COMMUNIQUÉ DE PRESSE
Valneva and Serum Institute of India Announce Discontinuation of Chikungunya Vaccine License Agreement
Valneva and Serum Institute of India mutually agree to discontinue chikungunya vaccine license. Valneva aims for direct control over supply chain and access to high-risk regions -
-
-
-
-
-